These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12043849)

  • 1. Differential effects of the antipsychotics haloperidol and clozapine on G protein measures in mononuclear leukocytes of patients with schizophrenia.
    Avissar S; Roitman G; Schreiber G
    Cell Mol Neurobiol; 2001 Dec; 21(6):799-811. PubMed ID: 12043849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G proteins as a biochemical tool for diagnosis and monitoring treatments of mental disorders.
    Schreiber G; Avissar S
    Isr Med Assoc J; 2000 Jul; 2 Suppl():86-91. PubMed ID: 10909424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Gs protein function and G alpha s levels in leukocytes of patients with Parkinson's disease.
    Avissar S; Barki-Harrington L; Herishanu Y; Schreiber G
    Mov Disord; 1997 Mar; 12(2):167-74. PubMed ID: 9087974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice.
    Thomsen M; Wörtwein G; Fink-Jensen A; Woldbye DP; Wess J; Caine SB
    Psychopharmacology (Berl); 2007 May; 192(1):97-110. PubMed ID: 17310388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats.
    See RE; Toga AW; Ellison G
    J Neural Transm Gen Sect; 1990; 82(2):93-109. PubMed ID: 1977417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.
    Zhao C; Li M
    Neuroscience; 2010 Apr; 166(4):1043-55. PubMed ID: 20096751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of early events in signal transduction beyond receptors involving G proteins function in mononuclear leucocytes.
    Avissar S; Schreiber G
    J Neuroimmunol; 1996 Oct; 70(1):81-6. PubMed ID: 8862138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats.
    Addy N; Levin ED
    Neuropsychopharmacology; 2002 Oct; 27(4):534-41. PubMed ID: 12377390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies.
    Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
    Neuropsychopharmacology; 2007 Jul; 32(7):1540-9. PubMed ID: 17164815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression.
    Zink M; Schmitt A; May B; Müller B; Demirakca T; Braus DF; Henn FA
    Schizophr Res; 2004 Feb; 66(2-3):151-7. PubMed ID: 15061247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated dopamine receptor-coupled G(s) protein measures in mononuclear leukocytes of patients with schizophrenia.
    Avissar S; Barki-Harrington L; Nechamkin Y; Roitman G; Schreiber G
    Schizophr Res; 2001 Jan; 47(1):37-47. PubMed ID: 11163543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.
    Wiley JL; Kendler SH; Burston JJ; Howard DR; Selley DE; Sim-Selley LJ
    Neuropharmacology; 2008 Dec; 55(7):1183-90. PubMed ID: 18708079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine.
    Werme M; Ringholm A; Olson L; Brené S
    Brain Res; 2000 Apr; 863(1-2):112-9. PubMed ID: 10773199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.
    Yu J; Källström L; Wiesel FA; Johnson AE
    Synapse; 1999 Dec; 34(3):192-207. PubMed ID: 10523757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action.
    Kapur S; McClelland RA; VanderSpek SC; Wadenberg ML; Baker G; Nobrega J; Zipursky RB; Seeman P
    Neuroreport; 2002 May; 13(6):831-5. PubMed ID: 11997696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.